Abstract
We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.
| Original language | English |
|---|---|
| Pages (from-to) | 642-644 |
| Number of pages | 3 |
| Journal | Journal of the Formosan Medical Association |
| Volume | 93 |
| Issue number | 7 |
| Publication status | Published - 1994 |
| Externally published | Yes |
Keywords
- Chlamydia pneumoniae
- azithromycin
ASJC Scopus subject areas
- Medicine(all)